# Ancillary Services Group

> **NIH NIH UM2** · RHO FEDERAL SYSTEMS DIVISION, INC. · 2020 · $351,660

## Abstract

PROJECT SUMMARY/ABSTRACT—ANCILLARY SERVICES GROUP 
 The Ancillary Services Group (ASG) will provide centralized support across the Disease-Specific Groups 
and studies for provision of materials for laboratory testing, sample tracking, and assay data transfer from 
central/mechanistic laboratories except for the Immune Tolerance Network (ITN), which is handled by a 
different contract. Through the management of a subcontractor for specimen collection supplies, Rho has 
provided operational support for 2 DAIT-funded consortia – Clinical Trials in Organ Transplantation (CTOT) 
and Clinical Trials in Organ Transplantation in Children (CTOT-C), as well as the Scleroderma 
Cyclophosphamide or Transplantation (SCOT) study funded under the Autoimmune Disease Clinical Trials 
(ADCT) project. Rho currently uses 2 sample tracking systems, Sampleminded® or RhoLAB™, to manage the 
collection, shipping, and tracking of biological specimens, environmental samples, and other materials 
collected in DAIT mechanistic studies and clinical trials. Sampleminded® is commercial software with a 
monthly subscription fee per user that has been successfully used on over 30 DAIT-sponsored studies across 
consortia, including CTOT/CTOT-C, ITN and the Clinical Islet Transplantation (CIT) Consortium. RhoLAB™ is 
a proprietary, in-house system that has been successfully employed for over 20 DAIT-sponsored studies 
across consortia, including Atopic Dermatitis Research Network (ADRN) and ADCT. 
 The goals of the ASG are to provide consistency across Disease-Specific Groups and studies through 
standardized processes, and facilitate integration of methodology and practices at study levels conducted by 
the consortia and to facilitate open lines of communication between each Disease-Specific Group and NIH 
project office(s) in setting priorities and timelines. Rho proposes to achieve these goals through the use of 
common tools, processes and reports across the Disease-Specific Groups to allow for more efficient tracking, 
reconciliation, and analysis of specimen/assay data.

## Key facts

- **NIH application ID:** 9927581
- **Project number:** 5UM2AI117870-06
- **Recipient organization:** RHO FEDERAL SYSTEMS DIVISION, INC.
- **Principal Investigator:** GLORIA L DAVID
- **Activity code:** UM2 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $351,660
- **Award type:** 5
- **Project period:** 2020-05-01 → 2022-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9927581

## Citation

> US National Institutes of Health, RePORTER application 9927581, Ancillary Services Group (5UM2AI117870-06). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/9927581. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
